Cornea Genetic Eye Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT01081561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Yaron S. Rabinowitz M.D.